Skip to main content
Equibles

Gallacher Capital Management LLC

Position in FLNA — Filana Therapeutics, Inc.

CIK 1960749 LONE TREE, CO
Back to FLNA Full portfolio

Position in FLNA

as of Mar 31, 2026 · filed May 6, 2026
Position Value
$109,802
-$18,848 QoQ
Shares Held
64,972
-0.0% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in FLNA Over Time

Shares Held

Position Value (USD)

Derivatives in FLNA

reported options exposure · as of Dec 31, 2024
CallValue
$198
CallShares
19,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Gallacher Capital Management LLC holds $2,342,787 across 8 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 10,486 $570,543
2 HALO
Halozyme Therapeutics, Inc.
 5,264 $412,013
3 GMAB
Genmab A/S
 14,240 $391,172
4 ARGX
Argenx SE
 304 $282,042
5 HRMY
Harmony Biosciences Holdings, Inc.
 6,666 $242,709
6 BNTX
BioNTech SE
 2,448 $227,786
7 INVA
Innoviva, Inc.
 9,067 $205,911
8 ANVS
Annovis Bio, Inc.
 5,705 $10,611

All Filings in FLNA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $109,802 64,972
2025-12-31 $128,650 64,975
2025-09-30 $189,077 64,975
2025-06-30 $117,604 64,975
2025-03-31 $104,490 69,660
2024-12-31 $360,952 152,946
2024-12-31 $198 19,800
2024-09-30 $17,070,636 580,042
2024-09-30 $688,662 23,400
2024-06-30 $169,883 16,100
2024-06-30 $7,193,726 582,488
2024-03-31 $11,877,380 585,381
2023-12-31 $13,091,951 581,606
2023-09-30 $9,614,991 577,824
2023-06-30 $14,302,319 583,292
2023-06-30 $13,506 17,300
2023-03-31 $14,180,606 587,919
2022-12-31 $26,176 50,100
2022-12-31 $17,385,264 588,533